RB1 and retinoblastoma: Nevertheless, we should focus on novel therapeutic approaches targeting to other molecular aberrations which might have roles in the progression of retinoblastoma, because Rb1 mutation is not a sufficient condition for the malignant characteristics of retinoblastoma cells [22, 23].